Resources & Guides

Complete Zepbound (tirzepatide) dosage chart for weight management. Covers the full 2.5 mg to 15 mg titration schedule, SURMOUNT-1 weight loss by dose, KwikPen guide, missed-dose rules, and a Zepbound vs Wegovy comparison.

The Zepbound KwikPen list price is $1,086.37 a month without insurance. The LillyDirect Self Pay Journey Program (launched February 2026) brings cash-pay vials down to $299 for 2.5mg, $399 for 5mg, and $449 for every dose from 7.5mg to 15mg when you refill within 45 days. This guide covers Zepbound pricing only, with no Mounjaro overlap.

Zepbound side effects guide: nausea 25-29%, diarrhea 19-23%, symptom timeline, serious warnings, and practical management tips for weight loss patients.

Zepbound contains tirzepatide, a dual agonist that activates both GLP-1 and GIP receptors simultaneously. Here is exactly what happens in your body, what SURMOUNT-1 showed at 72 weeks, and why the 5-day half-life matters for your dose schedule.

The ultimate retatrutide resource hub. Learn about this investigational triple-agonist, its remarkable Phase 2 results, dosing schedules, microdosing protocols, and use our free calculator to plan your journey.

With commercial coverage of the Zepbound single-dose pen and the savings card, eligible patients pay as little as $25 per fill, with savings capped at $1,300 per calendar year on that tier. Medicare beneficiaries have a new route from July 1, 2026: the CMS GLP-1 Bridge, which covers the Zepbound KwikPen only at $50 a month. This guide covers the insured path, prior authorization, and appeals.

Tirzepatide is a dual GIP/GLP-1 receptor agonist approved as Mounjaro (type 2 diabetes) and Zepbound (weight loss, sleep apnea). Clinical trials show up to 20.9% weight loss. This guide explains the science clearly.

Both Ozempic and Wegovy contain semaglutide, but Ozempic is FDA-approved for type 2 diabetes (max 1.0 mg) while Wegovy targets obesity (2.4 mg recommended maintenance, 7.2 mg maximum). Explore the differences.